Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
Malware can be encoded into a gene and used to take over a computer program.
Chinese scientists can be paid up to $165K for publishing a single paper in a top Western journal. The first study of payments to Chinese scientists for publishing in high-impact journals has serious implications for the future of research.
High-bandwidth connections into the brain could treat blindness, paralysis, and speech disorders.
The world’s most potent technologists are stranded in today’s innovation ecosystem.
It’s another blow to an industry that has been hammered in the U.S. and Europe, leaving a huge opportunity for China to emerge as a global leader in nuclear technology.
The president’s proposed cuts to research funding would cripple American innovation. We should be spending more on R&D, not less.
As climate change accelerates, a handful of scientists are eager to move ahead with experiments testing ways to counteract warming artificially.
There’s a big problem with AI: even its creators can’t explain how it works
Entrepreneurs are betting on apps that improve—or just replace—prescription medication.
Berners-Lee says Web access is a human right—and the technology he created needs a rethink.
10 breakthrough technologies that will affect the economy and politics, improve medicine, or influence our culture.
Surging investment in machine learning is vaulting Google into the scientific stratosphere.
New techniques being used to produce our food or shape the environment raise regulatory questions.
The dispute between researchers at UC Berkeley and the Broad Institute over the invention of the powerful gene-editing technique has been decided.
The work could lead to a new approach to the study of what is possible, and how it follows from what already exists.
The technique could be faster and more versatile than developing GMO crops from scratch.
Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google’s anti-aging spinout Calico is rich enough to find out.
New evidence in the battle to control a gene-editing technology that is worth billions.
Funding for British research and innovation is only one reason.
If academic discoveries turn out to be wrong, one drug company wants its money back.